Cargando…

Genetic Modifiers of Hereditary Neuromuscular Disorders and Cardiomyopathy

Novel genetic variants exist in patients with hereditary neuromuscular disorders (NMD), including muscular dystrophy. These patients also develop cardiac manifestations. However, the association between these gene variants and cardiac abnormalities is understudied. To determine genetic modifiers and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bazrafshan, Sholeh, Kushlaf, Hani, Kakroo, Mashhood, Quinlan, John, Becker, Richard C., Sadayappan, Sakthivel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915259/ https://www.ncbi.nlm.nih.gov/pubmed/33567613 http://dx.doi.org/10.3390/cells10020349

Ejemplares similares

South Asian-Specific MYBPC3(Δ25bp) Deletion Carriers Display Hypercontraction and Impaired Diastolic Function Under Exercise Stress
por: Bazrafshan, Sholeh, et al.
Publicado: (2021)

A Novel Homozygous Intronic Variant in TNNT2 Associates With Feline Cardiomyopathy
por: McNamara, James W., et al.
Publicado: (2020)

Recent Advances in the Molecular Genetics of Familial Hypertrophic Cardiomyopathy in South Asian Descendants
por: Kraker, Jessica, et al.
Publicado: (2016)

Stent placement for long-segment total occlusion of an aberrant right subclavian artery: A 7-year follow-up
por: Burket, Grace J, et al.
Publicado: (2020)

The prevalence of hereditary neuromuscular disorders in Northern Norway
por: Müller, Kai Ivar, et al.
Publicado: (2020)

Mutations in myosin S2 alter cardiac myosin-binding protein-C interaction in hypertrophic cardiomyopathy in a phosphorylation-dependent manner
por: Singh, Rohit R., et al.
Publicado: (2021)

Monoclonal Antibody-Based Immunotherapy and Its Role in the Development of Cardiac Toxicity
por: Kumar, Mohit, et al.
Publicado: (2020)

Upregulated Angiogenesis Is Incompetent to Rescue Dilated Cardiomyopathy Phenotype in Mice
por: Arif, Mohammed, et al.
Publicado: (2021)

High-Throughput Diagnostic Assay for a Highly Prevalent Cardiomyopathy-Associated MYBPC3 Variant
por: Barefield, David Y, et al.
Publicado: (2016)

Genetics of Neuromuscular Disorders
por: Seashore, Margretta R.
Publicado: (1990)

Hereditary Dilated Cardiomyopathy: Recent Advances in Genetic Diagnostics
por: Park, Hyun-Young
Publicado: (2017)

Neuromuscular diseases with hypertrophic cardiomyopathy
por: Cesar, Sergi
Publicado: (2018)

Myofilament Alterations Associated with Human R14del-Phospholamban Cardiomyopathy
por: Kumar, Mohit, et al.
Publicado: (2023)

Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage
por: Viswanathan, Shiv Kumar, et al.
Publicado: (2017)

Etiology of genetic muscle disorders induced by mutations in fast and slow skeletal MyBP-C paralogs
por: Song, Taejeong, et al.
Publicado: (2023)

Dilated cardiomyopathy-mediated heart failure induces a unique skeletal muscle myopathy with inflammation
por: Song, Taejeong, et al.
Publicado: (2019)

Hereditary transthyretin amyloid cardiomyopathy
por: Zheng, Yiliang, et al.
Publicado: (2023)

Optimization of tamoxifen-induced gene regulation in cardiovascular research
por: Sukumaran, Abitha, et al.
Publicado: (2022)

A rare overlap of statin-induced anti-3-hydroxy-3-methyl-glutaryl-coenzyme A necrotizing autoimmune myositis and dermatomyositis
por: Parikh, Priya, et al.
Publicado: (2021)

Noncompaction in Healthy Subjects, Dilated and Hypertrophic Cardiomyopathy, and Neuromuscular Disorders Is the Same Entity
por: Stollberger, Claudia, et al.
Publicado: (2015)

Surviving the infarct: A profile of cardiac myosin binding protein-C pathogenicity, diagnostic utility, and proteomics in the ischemic myocardium
por: Lynch, Thomas L, et al.
Publicado: (2014)

Oxidative Stress in Dilated Cardiomyopathy Caused by MYBPC3 Mutation
por: Lynch, Thomas L., et al.
Publicado: (2015)

Facilitations and Hurdles of Genetic Testing in Neuromuscular Disorders
por: Barp, Andrea, et al.
Publicado: (2021)

Heterogeneous Distribution of Genetic Mutations in Myosin Binding Protein-C Paralogs
por: Desai, Darshini A., et al.
Publicado: (2022)

Cardiac Myosin Binding Protein C Phosphorylation Affects Cross-Bridge Cycle's Elementary Steps in a Site-Specific Manner
por: Wang, Li, et al.
Publicado: (2014)

Patient preference for virtual versus in‐person visits in neuromuscular clinical practice
por: Hafeez, Komal, et al.
Publicado: (2022)

Leber’s Hereditary Optic Neuropathy and Hypertrophic Cardiomyopathy
por: Hey, Thomas Morris, et al.
Publicado: (2022)

Reliability of home-based, motor function measure in hereditary neuromuscular diseases
por: Ruiz-Cortes, Xiomara, et al.
Publicado: (2017)

Basic Cardiovascular Sciences Scientific Sessions 2020: Emerging Opportunities in Cardiovascular Diseases
por: Sadayappan, Sakthivel, et al.
Publicado: (2020)

Role of Radiologic Imaging in Genetic and Acquired Neuromuscular Disorders
por: Ortolan, Paolo, et al.
Publicado: (2015)

Neuromuscular disorders: genes, genetic counseling and therapeutic trials
por: Zatz, Mayana, et al.
Publicado: (2016)

Knockout of Sorbin And SH3 Domain Containing 2 (Sorbs2) in Cardiomyocytes Leads to Dilated Cardiomyopathy in Mice
por: McLendon, Jared M., et al.
Publicado: (2022)

Neuromuscular Disorders
por: Nair, Muralidharan
Publicado: (2019)

A Case of Early Hereditary Transthyretin Amyloid Cardiomyopathy Recognition With Genetic Screening: A Case Report
por: Juarez, Michel, et al.
Publicado: (2022)

Clinical, Genetic, and Histological Characterization of Patients with Rare Neuromuscular and Mitochondrial Diseases Presenting with Different Cardiomyopathy Phenotypes
por: Monda, Emanuele, et al.
Publicado: (2023)

Distal Arthrogryposis and Lethal Congenital Contracture Syndrome – An Overview
por: Desai, Darshini, et al.
Publicado: (2020)

Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy
por: Barp, Andrea, et al.
Publicado: (2015)

Hypertrophic Cardiomyopathy: Genetic Foundations, Outcomes, Interconnections, and Their Modifiers
por: Glavaški, Mila, et al.
Publicado: (2023)

Loss of Lipocalin 10 Exacerbates Diabetes-Induced Cardiomyopathy via Disruption of Nr4a1-Mediated Anti-Inflammatory Response in Macrophages
por: Li, Qianqian, et al.
Publicado: (2022)

Genetic modifiers ameliorate endocytic and neuromuscular defects in a model of spinal muscular atrophy
por: Walsh, Melissa B., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2usosiqkp9khdttrs1s67bdu8o